Health Care & Life Sciences » Medical Equipment & Supplies | Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. | Income Statement

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
13,090
16,890
16,965
18,274
20,918
24,358
Cost of Goods Sold (COGS) incl. D&A
7,465
9,004
9,127
9,692
11,239
13,370
Gross Income
5,626
7,886
7,838
8,582
9,679
10,988
SG&A Expense
3,756
5,457
5,258
5,627
6,302
6,995
EBIT
1,799
2,348
-
2,859
3,267
3,872
Unusual Expense
211
290
17
497
217
50
Non Operating Income/Expense
34
119
157
83
110
30
Interest Expense
262
480
415
470
592
667
Pretax Income
1,320
2,087
1,936
2,024
2,429
3,262
Income Tax
40
192
44
1
201
324
Consolidated Net Income
1,279
1,896
1,980
2,025
2,228
2,938
Net Income
1,279
1,896
1,980
2,025
2,228
2,938
Net Income After Extraordinaries
1,285
1,897
1,985
2,029
2,231
2,938
Net Income Available to Common
1,278
1,894
1,975
2,022
2,225
2,938
EPS (Basic)
3.48
4.71
4.92
5.09
5.59
7.24
Basic Shares Outstanding
360
398
399
395
395
402
EPS (Diluted)
3.48
4.71
4.92
5.09
5.59
7.24
Diluted Shares Outstanding
366
402
402
397
398
406
EBITDA
2,799
4,033
4,183
4,617
5,300
6,138
Other Operating Expense
71
81
85
96
110
121
Non-Operating Interest Income
28
48
31
48
81
137

About Thermo Fisher Scientific

View Profile
Address
168 Third Avenue
Waltham Massachusetts 02451
United States
Employees -
Website http://www.thermofisher.com
Updated 07/08/2019
Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions; Analytical Instruments; Specialty Diagnostics; and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease.

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.